Amgen’s trial drug to fight autoimmune disorder improves patient outcomes
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial
IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain
September 24, 2024: Teva Pharmaceuticals presented new research demonstrating effective strategies for switching adult patients with schizophrenia from Perseris to Uzedy (risperidone extended-release
The US national public agency has issued a Health Alert Network on the ongoing outbreak of the Clade I monkeypox virus, warning its
About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an
A new sensor technology designed and developed by professors and doctors at Cambridge University Hospitals may soon make hip surgery more precise and
HQ Team September 22, 2024: AstraZeneca’s Flumist, the first at-home flu vaccine, got approved by the Food and Drug Administration, enabling consumers with
Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or